Preincubation With Everolimus and Sirolimus Reduces Organic Anion-Transporting Polypeptide (OATP)1B1- and 1B3-Mediated Transport Independently of mTOR Kinase Inhibition: Implication in Assessing OATP1B1- and OATP1B3-Mediated Drug-Drug Interactions-Reference-Cited by-同舟云学术

Preincubation With Everolimus and Sirolimus Reduces Organic Anion-Transporting Polypeptide (OATP)1B1- and 1B3-Mediated Transport Independently of mTOR Kinase Inhibition: Implication in Assessing OATP1B1- and OATP1B3-Mediated Drug-Drug Interactions

Published:2019-10 Issue:10 Volume:108 Page:3443-3456
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Farasyn Taleah,Crowe Alexandra,Hatley Oliver,Neuhoff Sibylle,Alam Khondoker,Kanyo Jean,Lam TuKiet T.,Ding Kai,Yue Wei

Funder

National Institutes of Health

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference83 articles.

1. Uptake transporters of the human OATP family: molecular characteristics, substrates, their role in drug-drug interactions, and functional consequences of polymorphisms;König;Handb Exp Pharmacol,2011

2. Inhibition of transporter-mediated hepatic uptake as a mechanism for drug-drug interaction between cerivastatin and cyclosporin A;Shitara;J Pharmacol Exp Ther,2003

3. SLCO1B1 variants and statin-induced myopathy--a genomewide study;N Engl J Med,2008

4. Comparing various in vitro prediction criteria to assess the potential of a new molecular entity to inhibit organic anion transporting polypeptide 1B1;Vaidyanathan;J Clin Pharmacol,2016

5. In Vitro Metabolism and Transporter Mediated Drug-Drug Interaction Studies Guidance for Industry,2017

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The reduced function allele SLCO1B1 c.521T>C is of no practical relevance for the renal graft function over the first post-transplant year in patients treated with mycophenolic acid;Pharmacogenetics and Genomics;2024-05-20

2. A review of fetal cell lines used during drug development: Focus on COVID-19 vaccines, transplant medications, and biologics;American Journal of Health-System Pharmacy;2024-02-13

3. Assessing Trans-Inhibition of OATP1B1 and OATP1B3 by Calcineurin and/or PPIase Inhibitors and Global Identification of OATP1B1/3-Associated Proteins;Pharmaceutics;2023-12-31

4. OATP Transporters in Hepatic and Intestinal Uptake of Orally Administered Drugs;Oral Bioavailability and Drug Delivery;2023-10-10

5. Potentiation of the Uricosuric Effect of Dotinurad byTrans-Inhibition of the Uric Acid Reabsorptive Transporter 1;Drug Metabolism and Disposition;2023-08-29